Saturday, June 20, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 132 of 1,261
  1. KR 20240032847

    CLDN18.2 및 CD3에 결합하는 이중특이 결합제

    ASTELLAS PHARMA EUROPE B V [NL] · Granted Mar 12, 2024 · Expires Mar 7, 2044

    granted
  2. CA 3266054

    COMPOSÉS DE N-MÉTHYL-4-(QUINOLIN-2-YL)PYRIDIN-2-AMINE

    ABBVIE DEUTSCHLAND [DE] · Granted Mar 7, 2024 · Expires Mar 2, 2044

    granted
  3. US 11918639

    Methods and compositions for inducing protective immunity against filovirus infection

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 5, 2024 · Expires Feb 29, 2044

    granted
  4. US 11918563

    Methods and compositions for treatment of epileptic disorders

    OVID THERAPEUTICS INC. · Granted Mar 5, 2024 · Expires Feb 29, 2044

    granted
  5. US 11918688

    Treatment of hip pain with sustained-release liposomal anesthetic compositions

    Pacira Pharmaceuticals, Inc. · Granted Mar 5, 2024 · Expires Feb 29, 2044

    granted
  6. US 11918640

    Methods of preparing anti-human papillomavirus antigen T cells

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 5, 2024 · Expires Feb 29, 2044

    granted
  7. US 11918646

    Dry adjuvanted immune stimulating compositions and use thereof for mucosal administration

    The Board of Regents of the University of Texas System · Granted Mar 5, 2024 · Expires Feb 29, 2044

    granted
  8. US 11919887

    Substituted tetrahydrofurans as modulators of sodium channels

    Vertex Pharmaceuticals Incorporated · Granted Mar 5, 2024 · Expires Feb 29, 2044

    granted
  9. US 11918594

    Multi-substituent psilocybin derivatives and methods of using

    Enveric Biosciences Canada Inc. · Granted Mar 5, 2024 · Expires Feb 29, 2044

    granted
  10. US 11919836

    Prodrugs of fencamfamine

    Praxis Bioresearch, LLC · Granted Mar 5, 2024 · Expires Feb 29, 2044

    granted
  11. US 11918627

    Dosage regimen for inhaled vasoactive intestinal polypeptide

    CENTURION ÌLAÇ SANAYI VE TICARET ANONIM SIRKETI · Granted Mar 5, 2024 · Expires Feb 29, 2044

    granted
  12. US 11919888

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Mar 5, 2024 · Expires Feb 29, 2044

    granted
  13. US 11918660

    Viral vectors for cancer therapy

    Krystal Biotech, Inc. · Granted Mar 5, 2024 · Expires Feb 29, 2044

    granted
  14. US 11918654

    Solid solution compositions and use in severe pain

    Infirst Healthcare Limited · Granted Mar 5, 2024 · Expires Feb 29, 2044

    granted
  15. US 11918642

    HIV vaccination compositions comprising vaccinia VLPS and plant-produced VLPS presenting HIV antigens

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Mar 5, 2024 · Expires Feb 29, 2044

    granted
  16. US 11918622

    Ready-to-use bivalirudin compositions

    MAIA PHARMACEUTICALS, INC. · Granted Mar 5, 2024 · Expires Feb 29, 2044

    granted
  17. US 11919965

    Methods of treating multiple myeloma with bispecific anti-BCMA x anti-CD3 antibodies

    REGENERON PHARMACEUTICALS, INC. · Granted Mar 5, 2024 · Expires Feb 29, 2044

    granted
  18. US 11918633

    Compositions of prokaryotic phenylalanine ammonia-lyase and methods of treating adolescent subjects

    BIOMARIN PHARMACEUTICAL INC. · Granted Mar 5, 2024 · Expires Feb 29, 2044

    granted
  19. US 11918638

    Recombinant respiratory syncytial virus strains comprising NS1 and NS2 gene shifts

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 5, 2024 · Expires Feb 29, 2044

    granted
  20. US 11918568

    Fused ring compound having urea structure

    SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · Granted Mar 5, 2024 · Expires Feb 29, 2044

    granted
  21. US 11918612

    Synergistic bacterial compositions and methods of production and use thereof

    Seres Therapeutics, Inc. · Granted Mar 5, 2024 · Expires Feb 29, 2044

    granted
  22. US 11918560

    Serine protease inhibitor for treating coronavirus infection

    RedHill Biopharma Ltd. · Granted Mar 5, 2024 · Expires Feb 29, 2044

    granted
  23. US 11918571

    Compounds and their methods of use

    PRAXIS PRECISION MEDICINES, INC. · Granted Mar 5, 2024 · Expires Feb 29, 2044

    granted
  24. US 11918578

    Methods for treating cholestasis

    MIRUM PHARMACEUTICALS, INC. · Granted Mar 5, 2024 · Expires Feb 29, 2044

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.